Biotech

All Articles

8 months after a $213M fundraise, genetics editor Tome creates reduces

.After increasing $213 million in 2023-- some of the year's most extensive private biotech rounds-- ...

BioMarin builds officer team along with biotech vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable leadership hirings, firings as well a...

Biopharma Q2 VC reached highest level since '22, while M&ampA decreased

.Equity capital funding into biopharma cheered $9.2 billion all over 215 sell the second fourth of t...

Bicara, Zenas look for IPOs to press late-phase possessions toward market

.Bicara Therapeutics as well as Zenas Biopharma have actually given new inspiration to the IPO marke...

Genentech to close cancer cells immunology research study department

.Genentech will shut its cancer cells immunology research study team, and also device head and also ...

Kezar loses sound lump however to confirm its own worth in stage 1 trial

.Kezar Life Sciences is falling its own unpromising period 1 strong tumor medicine as the biotech go...

Acelyrin drops izokibep, drops 3rd of team

.Even with izokibep maintaining its newly found winning streak in the medical clinic, Acelyrin is ac...

Rivus' phase 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing medication ap...

Ovid standstills preclinical job, IV course after soticlestat neglect

.Ovid Therapy presently disclosed last month that it was trimming back its head count as the firm ge...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Port

.Eli Lilly has opened a $700 million R&ampD center in the Boston ma Seaport, increasing its own RNA ...